Symbol="BOLT"
AssetType="Common Stock"
Name="Bolt Biotherapeutics"
Description="Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the discovery, development and commercialization of pharmaceutical products. The company is headquartered in Redwood city, California."
CIK="1641281"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="52560000"
EBITDA="-83084000"
PERatio="None"
PEGRatio="None"
BookValue="4.17"
DividendPerShare="0"
DividendYield="0"
EPS="-2.33"
RevenuePerShareTTM="0.18"
ProfitMargin="0"
OperatingMarginTTM="-12.59"
ReturnOnAssetsTTM="-0.217"
ReturnOnEquityTTM="-0.422"
RevenueTTM="6742000"
GrossProfitTTM="1620000"
DilutedEPSTTM="-2.33"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.246"
AnalystTargetPrice="5.17"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.3"
PriceToBookRatio="0.27"
EVToRevenue="270.65"
EVToEBITDA="1.024"
Beta="0.825"
num_52WeekHigh="2.68"
num_52WeekLow="1.18"
num_50DayMovingAverage="1.605"
num_200DayMovingAverage="1.477"
SharesOutstanding="37813300"
DividendDate="None"
ExDividendDate="None"
symbol="BOLT"
open="1.40"
high="1.43"
low="1.35"
price="1.36"
volume="29325.00"
latest_trading_day="2023-07-14"
previous_close="1.40"
change="-0.04"
change_percent="-2.8571%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="42"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="58"
Volume_recent_avg="200199"
Change_recent_avg="0.01"
Delta_recent_avg="0.11"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.25"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="58"
Aroon_momentum_negative="42"
image_negative_thumbnail_id_1="488"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0117.jpeg"
image_negative_thumbnail_id_2="167"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0009.jpeg"
image_neutral_thumbnail_id_1="554"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_neutral_thumbnail_id_2="524"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0075.jpeg"
image_positive_thumbnail_id_1="604"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0104.jpeg"
image_positive_thumbnail_id_2="973"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0135.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
